Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Pomerantz

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
The Journal of Infectious Diseases|December 1, 1991
Anti-human immunodeficiency virus type 1 activity of sulfated monosaccharides: comparison with sulfated polysaccharides and other polyionsO Bagasra, P Whittle, B Heins, et al.
Virology|January 6, 1997
Natural endogenous reverse transcription of simian immunodeficiency virusG Dornadula, H Zhang, O Bagasra, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 1, 1997
In situ PCR. Current protocolO Bagasra, M Mukhtar, F Shaheen, et al.
Journal of Virology|February 23, 2000
Partial rescue of the Vif-negative phenotype of mutant human immunodeficiency virus type 1 strains from nonpermissive cells by intravirion reverse transcriptionG Dornadula, S Yang, R J Pomerantz, et al.
Journal of Virology|August 23, 2000
Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging processH Zhang, R J Pomerantz, G Dornadula, et al.
Journal of Human Virology|July 6, 2000
Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral coreH Zhang, G Dornadula, J Orenstein, et al.
Journal of Virology|November 1, 1995
Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoterM Kundu, A Srinivasan, R J Pomerantz, et al.
Gastroenterology|September 1, 1993
Hepatitis A vaccines: past, present, and futureR S Eng, R J Pomerantz, L S Friedman
Human Gene Therapy|December 1, 1995
Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragmentsL Duan, M Zhu, O Bagasra, et al.
The Journal of Experimental Medicine|July 1, 1990
Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expressionR J Pomerantz, M B Feinberg, D Trono, et al.
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
The Journal of Infectious Diseases|December 1, 1991
Anti-human immunodeficiency virus type 1 activity of sulfated monosaccharides: comparison with sulfated polysaccharides and other polyionsO Bagasra, P Whittle, B Heins, et al.
Virology|January 6, 1997
Natural endogenous reverse transcription of simian immunodeficiency virusG Dornadula, H Zhang, O Bagasra, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 1, 1997
In situ PCR. Current protocolO Bagasra, M Mukhtar, F Shaheen, et al.
Journal of Virology|February 23, 2000
Partial rescue of the Vif-negative phenotype of mutant human immunodeficiency virus type 1 strains from nonpermissive cells by intravirion reverse transcriptionG Dornadula, S Yang, R J Pomerantz, et al.
Journal of Virology|August 23, 2000
Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging processH Zhang, R J Pomerantz, G Dornadula, et al.
Journal of Human Virology|July 6, 2000
Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral coreH Zhang, G Dornadula, J Orenstein, et al.
Journal of Virology|November 1, 1995
Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoterM Kundu, A Srinivasan, R J Pomerantz, et al.
Gastroenterology|September 1, 1993
Hepatitis A vaccines: past, present, and futureR S Eng, R J Pomerantz, L S Friedman
Human Gene Therapy|December 1, 1995
Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragmentsL Duan, M Zhu, O Bagasra, et al.
The Journal of Experimental Medicine|July 1, 1990
Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expressionR J Pomerantz, M B Feinberg, D Trono, et al.
Pageof 14